BMAL1 and leukemia: Together with the previous results related to where CLOCK and BMAL1 were down-regulated, it is possible that the up-regulation of SHARP1 is also involved in this repression mechanism, suggesting its oncogenic role in leukemia and its role as a biomarker, although further research is needed to verify it [89,91,92,175,176,177].